PUBLIC COMPANY
saveCSL Behring LLC
updated 2mo ago
CSL Behring is a biopharmaceutical company, manufacturing plasma-derived and recombinant therapeutic products. The company is a combination of Behringwerke, founded in 1904 in Marburg, Germany by Emil von Behring, and the Commonwealth Serum Laboratories (CSL), established in Australia in 1916 to provide vaccines to the people of Australia, as well as other companies acquired since 2004.
community read0 votes
pipeline
10
marketed
10
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(10)
pipeline depth10 products
10Marketed
Marketed
(coagulation factor VIII (human) + von willebrand factor complex (human))
Hemophilia A (Factor VIII Deficiency)
MarketedC1 esterase inhibitor (human)
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
MarketedHaegarda
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
MarketedKcentra
Bleeding And Clotting Disorders
Marketedalbutrepenonacog alfa LA
Hemophilia B (Factor IX Deficiency)
Marketedantihemophilic factor (recombinant), single chain
Hemophilia A (Factor VIII Deficiency)
Marketedcytomegalovirus immune globulin (human)
Cytomegalovirus (HHV-5) Infections
Marketedetranacogene dezaparvovec
Hemophilia B (Factor IX Deficiency)
Marketedfactor XIII (human)
Fibrin Stabilizing Factor Deficiency (Factor XIII Deficie…
Marketedgaradacimab
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-IN…
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- Chiesi to buy KalVista in $1.9B deal for rare disease drugThe acquisition is the fifth of a biotech company so far this week and, according to some Wall Street analysts, proves pharma’s interest in new and emerging oral therapies for hereditary angioedema.biopharma_dive · 3mo ago
- Drugmaker AbbVie chooses North Carolina for $1.4B manufacturing campusThe 185-acre site will be the company’s largest single investment to date, with a focus on small-volume parenteral products like vials and prefilled syringes.biopharma_dive · 3mo ago
comments(0)
5-min edit window · permanent after that